Current location:business >>
Chinese inhibitor drug candidate becomes first to enter phase
business3People have gathered around
IntroductionChinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chines ...
Chinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chinese regulatory authorities for the registration phase-3 clinical trial of a combination therapy using its SHP2 inhibitor drug candidate JAB-3312.
SHP2 inhibitors are expected worldwide to have a substantial clinical effect in cancer and immunity disease treatment, and the approval made JAB-3312 the first SHP2 inhibitor to enter the phase-3 clinical study globally.
The approved clinical study in China is designed to evaluate the efficacy and safety of JAB-3312 in combination with the company's other investigational drug candidate KRAS G12C inhibitor glecirasib, for treating first-line non-small cell lung cancer patients with KRAS G12C mutations.
The control arm is the current standard treatment for first-line non-small cell lung cancer, which is the combination therapy of PD-1 antibody and chemotherapy.
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“Global Gazetteer news portal”。http://iraq.chongwenmenhotelbeijing.com/html-82f099850.html
Related articles
Six killed in a 'foiled coup' in Congo, the army says
businessKINSHASA, Congo (AP) — Six people were killed and dozens arrested following attacks on the residence ...
【business】
Read moreChina's automobile manufacturing sector logs steady expansion in 2023
business(Xinhua) 10:09, February 14, 2024BEIJING, Feb. 13 (Xinhua) -- China's automobile manufacturing indus ...
【business】
Read moreChina remains world's largest engine for growth
businessBy Wu Lejun, Wu Qiuyu, Yu Yichun (People's Daily) 16:25, February 26, 2024Photo taken on Feb. 12, 20 ...
【business】
Read more
Popular articles
Latest articles
Russian theater director and playwright go on trial over a play authorities say justifies terrorism
Interview: Mercedes
Xinjiang sees record number of high
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
Company wins court ruling to continue development of Michigan factory serving EV industry
DeSmith stops 32 shots and Canucks sweep season series with 3
LINKS
- Israel will respond to genocide charges at UN court after South Africa urgently requests cease
- The Starmer Stone! Keir apes Blair
- Fury over 'rip
- Damaged air valve in field of cattle is blamed as the source of Devon's parasite outbreak
- Suspect in shooting of Slovak prime minister is escorted to his home as police search for evidence
- I'm a therapist... here's why women are attracted to 'bad boys'
- Federal agency takes control of investigation of fiery train derailment in New Mexico
- Mass poisoning at high
- 'ALL Brits are welcome!' Mayor of Magaluf's message to UK holidaymakers following 'tourism
- Has VAR broken the beautiful game? The hated technology's SIX biggest blunders, as fed